Plicamycin Interactions
There are 257 drugs known to interact with plicamycin. Of the total drug interactions, 80 are major, 159 are moderate, and 18 are minor.
Medications known to interact with plicamycin
Note: Showing generic names only.
A
- acalabrutinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- allopurinol
- anakinra
- anthrax vaccine adsorbed
- apixaban
- ardeparin
- atezolizumab
- avapritinib
- avelumab
- azathioprine
B
- baricitinib
- bcg
- bcg vaccine
- betrixaban
- bifidobacterium infantis
- bifidobacterium longum
- brewer's yeast
- bromfenac ophthalmic
C
- cabozantinib
- canakinumab
- candida albicans extract
- capsicum
- cemiplimab
- certolizumab
- chamomile
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- cholera vaccine, live
- cinoxacin
- ciprofloxacin
- citalopram
- cladribine
- clomipramine
- clozapine
- coccidioidin skin test
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
D
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferiprone
- delafloxacin
- dengue vaccine
- denosumab
- deoxycholic acid
- desvenlafaxine
- deucravacitinib
- dexfenfluramine
- diclofenac ophthalmic
- diclofenac topical
- diflunisal
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- drotrecogin alfa
- duloxetine
- durvalumab
E
- edoxaban
- efalizumab
- efbemalenograstim alfa
- eflapegrastim
- enoxacin
- enoxaparin
- epoprostenol
- escitalopram
- etanercept
- etrasimod
F
- fenfluramine
- fenugreek
- filgrastim
- fingolimod
- fluoxetine
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- foscarnet
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hemin
- heparin flush
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- horse chestnut
- human papillomavirus vaccine
I
- ibritumomab
- ibrutinib
- idelalisib
- iloprost
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- inotersen
- iodine i 131 tositumomab
- ipilimumab
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- levofloxacin
- levomilnacipran
- lomefloxacin
- loncastuximab tesirine
- lyme disease vaccine
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- milnacipran
- mixed respiratory vaccine
- monomethyl fumarate
- moxifloxacin
- mumps skin test antigen
- mumps virus vaccine
N
- nadofaragene firadenovec
- nalidixic acid
- natalizumab
- nepafenac ophthalmic
- niraparib
- nivolumab
- norfloxacin
O
P
- palifermin
- panobinostat
- paroxetine
- pegfilgrastim
- pembrolizumab
- pentosan polysulfate sodium
- pertussis, acellular
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponatinib
- ponesimod
- prasugrel
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- ramucirumab
- regorafenib
- retifanlimab
- rilonacept
- ritlecitinib
- rivaroxaban
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
S
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- sertraline
- sibutramine
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium phosphate p32
- sparfloxacin
- staphage lysate (spl)
- streptococcus salivarius
- strontium-89 chloride
- suprofen ophthalmic
T
- talimogene laherparepvec
- tbo-filgrastim
- teriflunomide
- tetanus toxoid
- thalidomide
- ticagrelor
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tinzaparin
- tipranavir
- tislelizumab
- tofacitinib
- topotecan
- toripalimab
- tositumomab
- tovorafenib
- tremelimumab
- treprostinil
- trichophyton skin test
- trovafloxacin
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
Y
Z
Report options
QR code containing a link to this page
More about plicamycin
- plicamycin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.